David Richards | Chief Executive Officer
Clarametyx

David Richards, Chief Executive Officer, Clarametyx

David Richards is a life sciences executive with expertise in corporate development, team building, operations, capital structuring, research and development, program management, and intellectual property development. Mr. Richards has served as Chief Executive Officer of Clarametyx Biosiences since 2020. Prior to Clarametyx, Mr. Richards served in operational and general counsel roles for Aclipse Therapeutics, which focuses on molecular pathways that regulate cellular stress, protein misfolding and inflammation in neurodegenerative and gastrointestinal disease areas; and N8 Biosciences, Inc., which is commercializing novel small molecule antimicrobial therapeutics and device coatings that mimic naturally occurring antimicrobial peptides. Prior to these roles, Mr. Richards served in operational and legal capacities for various startups, family office funds and was an associate at a large multinational law firm Latham & Watkins LLP. Mr. Richards received a bachelor’s degree in economics from Vanderbilt University and his JD from the University of Texas School of Law.

Appearances:



Day 2 - World Antimicrobial Resistance Congress & Disease Prevention Control Summit 2024 @ 11:00

Panel: Everything, everywhere, all at once. Why the common thread in resistant, infectious diseases may be biofilms

Sponsored by N8 Medical 

last published: 12/Jun/24 19:45 GMT
last published: 12/Jun/24 19:45 GMT

back to speakers


GET INVOLVED AT THE

WORLD ANTIMICROBIAL RESISTANCE CONGRESS

 

To Sponsor Or Exhibit

 


Justin Franks

justin.franks@terrapinn.com
+1 914 819 3506

 

To Speak


Kaylee Nguyen

kaylee.nguyen@terrapinn.com

 

 

Press & Media Partnerships

 


Kaylie Brogan

kaylie.brogan@terrapinn.com

 

 

Start-Ups & Posters

 


Semen Sen

semen.sen@terrapinn.com
+1 646.619.1793